review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Gregory P. Kalemkerian | Q124968136 |
P2860 | cites work | Novel systemic therapies for small cell lung cancer | Q33862245 |
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group | Q33870498 | ||
Prophylactic cranial irradiation in extensive small-cell lung cancer | Q34005742 | ||
Keynote address on biostatistics and data retrieval. | Q34213509 | ||
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung ca | Q34727531 | ||
Prognostic value of [18F]FDG-PET imaging in small cell lung cancer | Q35026333 | ||
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer | Q35966667 | ||
Prognostic significance of 18 F-fluorodeoxyglucose - positron emission tomography after treatment in patients with limited stage small cell lung cancer | Q36947998 | ||
High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer | Q38495862 | ||
Response of asymptomatic brain metastases from small-cell lung cancer to systemic first-line chemotherapy | Q40329404 | ||
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease? | Q40633491 | ||
A meta-analysis of thoracic radiotherapy for small-cell lung cancer | Q41086687 | ||
Is bone marrow examination in small-cell lung cancer really necessary? | Q42102108 | ||
High impact of 18F-FDG-PET on management and prognostic stratification of newly diagnosed small cell lung cancer | Q43239945 | ||
FDG-PET imaging for the staging and follow-up of small cell lung cancer | Q43611337 | ||
Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study | Q44023005 | ||
Whole-body 18F-2-deoxyglucose positron emission tomography in primary staging small cell lung cancer. | Q44095349 | ||
Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis | Q44493823 | ||
Small-cell lung cancer: state of the art. | Q44678752 | ||
Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer | Q44683647 | ||
Impact of positron emission tomography on the management of patients with small-cell lung cancer: preliminary experience | Q44824805 | ||
Can positron emission tomography be used as a staging tool for small-cell lung cancer? | Q44936116 | ||
Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer | Q44982573 | ||
Positron emission tomography in limited-stage small-cell lung cancer: a prospective study | Q45018077 | ||
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis | Q45371243 | ||
The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition | Q46106136 | ||
18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study | Q46700420 | ||
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. | Q50789972 | ||
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. | Q53189764 | ||
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. | Q53515309 | ||
Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET). | Q53572985 | ||
Bone marrow involvement in small cell lung cancer. Clinical significance and correlation with routine laboratory variables | Q69327137 | ||
The value of the bone scan and bone marrow biopsy staging small cell lung cancer | Q70089307 | ||
Positron emission tomography in the staging of small-cell lung cancer : a preliminary study | Q73598716 | ||
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide | Q77912158 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | positron emission tomography | Q208376 |
lung neoplasm | Q15124212 | ||
lung small cell carcinoma | Q19000544 | ||
P304 | page(s) | 253-8 | |
P577 | publication date | 2012-01-12 | |
P1433 | published in | Cancer Imaging | Q2577267 |
P1476 | title | Staging and imaging of small cell lung cancer | |
P478 | volume | 11 |
Q98735972 | Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score |
Q98226197 | Current Management and Progress in Radiotherapy for Small Cell Lung Cancer |
Q54953051 | Current standards for clinical management of small cell lung cancer. |
Q42059466 | Diagnostic accuracy of computed tomography imaging for the detection of differences between peripheral small cell lung cancer and peripheral non-small cell lung cancer |
Q91989840 | Real-world effectiveness and tolerability of small-cell lung cancer (SCLC) treatments: A systematic literature review (SLR) |
Q61807863 | Retrospective study of the efficacy and toxicity of lobaplatin-etoposide chemotherapy in small cell lung cancer |
Q60021974 | Small cell lung cancer |
Q58804836 | The evolving role of radiotherapy in the management of small cell lung cancer |
Search more.